Testing mirabegron and tadalafil to improve sugar control
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at whether mirabegron and tadalafil can improve blood sugar control in people with prediabetes. It may help determine if these medicines can slow the move from prediabetes toward diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prediabetes, with A1C between 5.7% and 6.4%
- Your body mass index (BMI) is between 27 and 45
- You do not have diabetes
- You are not taking diabetes medicines on a long-term basis
- You do not have a serious or unstable health problem that could make the study unsafe
- You can safely take mirabegron and tadalafil (no known allergy or other “not safe” reasons)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether a combination medicine—alpha-lipoic acid plus mirabegron—can help people manage obesity. It will study safety and whether the treatment can improve weight-related outcomes in adults.
This study tests whether a supplement called Glucocil can improve metabolic health (blood sugar and cholesterol) in people with prediabetes or early type 2 diabetes. The goal is to help manage these conditions with a natural option before needing prescription drugs.
This Phase 2 study tests whether a medication approach can activate “beige” fat, which may help the body burn more energy. It mainly looks for people with higher body weight and prediabetes who are not on diabetes medicines.
This study tests whether a Mediterranean diet can help people with prediabetes improve their blood sugar levels. You'll follow a specific meal plan for a period of time and have your blood sugar and other health markers checked.
This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).
This study tests a medicine called XBD173 to see how it affects blood sugar by targeting a protein inside cells' mitochondria. It may help people without diabetes learn about new ways to regulate blood sugar.
Hear when a new Pre Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.